Company Update (NYSE:BSX): Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

[PR Newswire] – MARLBOROUGH, Mass., March 24, 2015 /PRNewswire/ — This week, three patients in the United States received the first implants of the Boston Scientific Corporation (BSX) WATCHMAN™ Left Atrial Appendage Closure . . . → Read More: Company Update (NYSE:BSX): Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device Similar Articles: Company Update (NYSE:BSX): Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System Stock Update (NYSE:BSX): Boston Scientific To Host And Webcast Investor Day Business Review May 1, 2015 Stock Update (NYSE:BSX): FDA panel offers mixed view on Boston Scientific Watchman device